Walmart’s employees and their dependents are being offered expanded cancer treatment with doctors at the Mayo Clinic through ...

A recent analysis, published in The Lancet Oncology, calculates that increasing access to [¹⁷⁷Lu]PSMA therapy for eligible ...

Walmart is expanding its insurance coverage to offer advanced cancer treatment for employees and their dependents at the Mayo ...

The Food and Drug Administration expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat patients with earlier stages of the disease, drugmaker Novartis said Tuesday.

The potential market for the Novartis drug Kisqali could grow markedly, now that certain early-stage breast cancer patients ...

AstraZeneca AZN and partner Daiichi Sankyo announced that the FDA has accepted the supplemental biologics license application ...

A supplemental new drug application seeking expanded indication for darolutamide combined with androgen deprivation therapy ...

About three months from opening, the the new Nebraska Medicine cancer facility in Kearney now has a name: Nebraska Medicine ...

FDA has authorized the Expanded Access Policy (EAP ... Bria-IMT™ may provide a treatment option for cancer patients in need,” stated Dr. William V. Williams, BriaCell’s President and ...

Bayer plans to submit the data from the ARANOTE trial to health authorities globally to support the expanded use of darolutamide ... resistant prostate cancer (nmCRPC), who are at high risk ...

NUBEQA is currently indicated for the treatment of adult patients with mHSPC in combination with docetaxel and for non-metastatic castration-resistant prostate cancer (nmCRPC). Indices Commodities ...